• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嗜同性病毒整合位点 1 促进结肠癌细胞的转移,而不依赖于上皮-间充质转化。

Ecotropic viral integration site 1 promotes metastasis independent of epithelial mesenchymal transition in colon cancer cells.

机构信息

Department of Gene Function and Regulation, Institute of Life Sciences Nalco Square, Bhubaneswar, Odisha, India.

Department of Veterinary Pathology, College of Veterinary & Animal Sciences, Wayanad, Kerala, India.

出版信息

Cell Death Dis. 2018 Jan 16;9(2):18. doi: 10.1038/s41419-017-0036-1.

DOI:10.1038/s41419-017-0036-1
PMID:29339729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5833819/
Abstract

The most indecipherable component of solid cancer is the development of metastasis which accounts for more than 90% of cancer-related mortalities. A developmental program termed epithelial-mesenchymal transition (EMT) has also been shown to play a critical role in promoting metastasis in epithelium-derived solid tumors. By analyzing publicly available microarray datasets, we observed that ecotropic viral integration site 1 (EVI1) correlates negatively with SLUG, a master regulator of EMT. This correlation was found to be relevant as we demonstrated that EVI1 binds to SLUG promoter element directly through the distal set of zinc fingers and downregulates its expression. Many studies have shown that the primary role of SLUG during EMT and EMT-like processes is the regulation of cell motility in most of the cancer cells. Knockdown of EVI1 in metastatic colon cancer cell and subsequent passage through matrigel not only increased the invading capacity but also induced an EMT-like morphological feature of the cells, such as spindle-shaped appearance and led to a significant reduction in the expression of the epithelial marker, E-CADHERIN and increase in the expression of the mesenchymal marker, N-CADHERIN. The cells, when injected into immunocompromised mice, failed to show any metastatic foci in distant organs however the ones with EVI1, metastasized in the intraperitoneal layer and also showed multiple micro metastatic foci in the lungs and spleen. These findings suggest that in colon cancer EVI1 is dispensable for epithelial-mesenchymal transition, however, is required for metastasis.

摘要

实体瘤中最难以捉摸的部分是转移的发展,转移占癌症相关死亡的 90%以上。一个被称为上皮-间充质转化(EMT)的发育程序也被证明在促进上皮源性实体瘤转移中起着关键作用。通过分析公开的微阵列数据集,我们观察到,嗜性病毒整合位点 1(EVI1)与 EMT 的主调控因子 SLUG 呈负相关。这种相关性是相关的,因为我们证明 EVI1 通过远端锌指直接结合到 SLUG 启动子元件并下调其表达。许多研究表明,在 EMT 和 EMT 样过程中,SLUG 的主要作用是调节大多数癌细胞的细胞迁移能力。在转移性结肠癌细胞中敲低 EVI1,随后通过基质胶进行传代,不仅增加了侵袭能力,而且诱导细胞出现 EMT 样形态特征,如纺锤形外观,并导致上皮标志物 E-钙黏蛋白的表达显著减少,间充质标志物 N-钙黏蛋白的表达增加。当这些细胞被注射到免疫缺陷小鼠中时,在远处器官中没有显示出任何转移灶,但那些有 EVI1 的细胞在腹膜层转移,并在肺部和脾脏中显示出多个微转移灶。这些发现表明,在结肠癌中,EVI1 对于上皮-间充质转化不是必需的,但对于转移是必需的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad7/5833819/c264879ce5f9/41419_2017_36_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad7/5833819/5aa7adbc144f/41419_2017_36_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad7/5833819/f316dd938491/41419_2017_36_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad7/5833819/0b5394aa92f1/41419_2017_36_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad7/5833819/bf1a53d626d8/41419_2017_36_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad7/5833819/b134961370b0/41419_2017_36_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad7/5833819/055b61439f69/41419_2017_36_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad7/5833819/08d2a91d941a/41419_2017_36_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad7/5833819/c264879ce5f9/41419_2017_36_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad7/5833819/5aa7adbc144f/41419_2017_36_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad7/5833819/f316dd938491/41419_2017_36_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad7/5833819/0b5394aa92f1/41419_2017_36_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad7/5833819/bf1a53d626d8/41419_2017_36_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad7/5833819/b134961370b0/41419_2017_36_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad7/5833819/055b61439f69/41419_2017_36_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad7/5833819/08d2a91d941a/41419_2017_36_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad7/5833819/c264879ce5f9/41419_2017_36_Fig8_HTML.jpg

相似文献

1
Ecotropic viral integration site 1 promotes metastasis independent of epithelial mesenchymal transition in colon cancer cells.嗜同性病毒整合位点 1 促进结肠癌细胞的转移,而不依赖于上皮-间充质转化。
Cell Death Dis. 2018 Jan 16;9(2):18. doi: 10.1038/s41419-017-0036-1.
2
EVI1 promotes metastasis by downregulating TIMP2 in metastatic colon and breast cancer cells.EVI1 通过下调转移性结肠和乳腺癌细胞中的 TIMP2 促进转移。
Int J Biochem Cell Biol. 2022 Jan;142:106118. doi: 10.1016/j.biocel.2021.106118. Epub 2021 Nov 18.
3
EVI1 promotes epithelial-to-mesenchymal transition, cancer stem cell features and chemo-/radioresistance in nasopharyngeal carcinoma.EVI1 促进鼻咽癌中的上皮间质转化、癌症干细胞特征和化疗/放疗抵抗。
J Exp Clin Cancer Res. 2019 Feb 15;38(1):82. doi: 10.1186/s13046-019-1077-3.
4
EVI‑1 acts as an oncogene and positively regulates calreticulin in breast cancer.EVI‑1 作为一种癌基因,正向调控乳腺癌中的钙网织蛋白。
Mol Med Rep. 2019 Mar;19(3):1645-1653. doi: 10.3892/mmr.2018.9796. Epub 2018 Dec 24.
5
HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.HMGA2 诱导转录因子 Slug 的表达,促进上皮间质转化,促进结肠癌的进展。
Cancer Lett. 2014 Dec 1;355(1):130-40. doi: 10.1016/j.canlet.2014.09.007. Epub 2014 Sep 11.
6
[Inhibition of Histone Deacetylases Reverses Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells through a Slug Mediated Mechanism].[组蛋白去乙酰化酶的抑制通过一种Slug介导的机制逆转三阴性乳腺癌细胞中的上皮-间质转化]
Mol Biol (Mosk). 2018 May-Jun;52(3):474-481. doi: 10.7868/S0026898418030102.
7
FERMT1 mediates epithelial-mesenchymal transition to promote colon cancer metastasis via modulation of β-catenin transcriptional activity.FERMT1通过调节β-连环蛋白转录活性介导上皮-间质转化以促进结肠癌转移。
Oncogene. 2017 Mar 30;36(13):1779-1792. doi: 10.1038/onc.2016.339. Epub 2016 Sep 19.
8
PTEN inactivation induces epithelial-mesenchymal transition and metastasis by intranuclear translocation of β-catenin and snail/slug in non-small cell lung carcinoma cells.PTEN 失活通过β-连环蛋白和 snail/slug 的核内易位诱导非小细胞肺癌细胞发生上皮-间充质转化和转移。
Lung Cancer. 2019 Apr;130:25-34. doi: 10.1016/j.lungcan.2019.01.013. Epub 2019 Jan 29.
9
MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer.微小RNA-30a通过靶向乳腺癌中的Slug增加紧密连接蛋白表达,从而抑制上皮-间质转化和转移。
Oncotarget. 2016 Mar 29;7(13):16462-78. doi: 10.18632/oncotarget.7656.
10
Metformin mediated reversal of epithelial to mesenchymal transition is triggered by epigenetic changes in E-cadherin promoter.二甲双胍介导的上皮-间质转化逆转是由E-钙黏蛋白启动子的表观遗传变化触发的。
J Mol Med (Berl). 2016 Dec;94(12):1397-1409. doi: 10.1007/s00109-016-1455-7. Epub 2016 Aug 17.

引用本文的文献

1
Epigenetic targeting of MECOM/KRAS axis by JIB-04 impairs tumorigenesis and cisplatin resistance in MECOM-amplified ovarian cancer.JIB-04对MECOM/KRAS轴的表观遗传靶向作用可削弱MECOM扩增型卵巢癌的肿瘤发生及顺铂耐药性。
Cell Death Discov. 2025 Jul 15;11(1):326. doi: 10.1038/s41420-025-02618-2.
2
The Pivotal Role of One-Carbon Metabolism in Neoplastic Progression During the Aging Process.一碳代谢在衰老过程中肿瘤进展中的关键作用。
Biomolecules. 2024 Oct 31;14(11):1387. doi: 10.3390/biom14111387.
3
Deciphering the Potentials of Cardamom in Cancer Prevention and Therapy: From Kitchen to Clinic.

本文引用的文献

1
Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition.干细胞样转录重编程介导对mTOR抑制的转移抗性。
Oncogene. 2017 May 11;36(19):2737-2749. doi: 10.1038/onc.2016.427. Epub 2016 Dec 19.
2
Ecotropic viral integration site 1, a novel oncogene in prostate cancer.嗜亲性病毒整合位点1,前列腺癌中的一种新型致癌基因。
Oncogene. 2017 Mar;36(11):1573-1584. doi: 10.1038/onc.2016.325. Epub 2016 Sep 12.
3
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance.
解析小豆蔻在癌症预防和治疗中的潜力:从厨房到临床。
Biomolecules. 2024 Sep 18;14(9):1166. doi: 10.3390/biom14091166.
4
Graphene-Based Photodynamic Therapy and Overcoming Cancer Resistance Mechanisms: A Comprehensive Review.基于石墨烯的光动力疗法及克服癌症耐药机制:全面综述。
Int J Nanomedicine. 2024 Jun 11;19:5637-5680. doi: 10.2147/IJN.S461300. eCollection 2024.
5
The ETV6-MECOM fusion protein promotes EMT-related properties by repressing the transactivation activity of E-cadherin promoter in K562 leukemia cells.ETV6-MECOM融合蛋白通过抑制K562白血病细胞中E-钙黏蛋白启动子的反式激活活性来促进上皮-间质转化相关特性。
Biochem Biophys Rep. 2024 Feb 19;38:101667. doi: 10.1016/j.bbrep.2024.101667. eCollection 2024 Jul.
6
EVI1 in Leukemia and Solid Tumors.白血病和实体瘤中的EVI1
Cancers (Basel). 2020 Sep 18;12(9):2667. doi: 10.3390/cancers12092667.
7
Multifaceted Role of PRDM Proteins in Human Cancer.PRDM 蛋白在人类癌症中的多方面作用。
Int J Mol Sci. 2020 Apr 10;21(7):2648. doi: 10.3390/ijms21072648.
8
EVI1 as a Marker for Lymph Node Metastasis in HNSCC.EVI1 作为头颈部鳞癌淋巴结转移的标志物。
Int J Mol Sci. 2020 Jan 28;21(3):854. doi: 10.3390/ijms21030854.
9
EVI1 promotes epithelial-to-mesenchymal transition, cancer stem cell features and chemo-/radioresistance in nasopharyngeal carcinoma.EVI1 促进鼻咽癌中的上皮间质转化、癌症干细胞特征和化疗/放疗抵抗。
J Exp Clin Cancer Res. 2019 Feb 15;38(1):82. doi: 10.1186/s13046-019-1077-3.
10
EVI‑1 acts as an oncogene and positively regulates calreticulin in breast cancer.EVI‑1 作为一种癌基因,正向调控乳腺癌中的钙网织蛋白。
Mol Med Rep. 2019 Mar;19(3):1645-1653. doi: 10.3892/mmr.2018.9796. Epub 2018 Dec 24.
上皮-间质转化并非肺转移所必需,但会导致化疗耐药。
Nature. 2015 Nov 26;527(7579):472-6. doi: 10.1038/nature15748. Epub 2015 Nov 11.
4
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.上皮-间质转化对胰腺癌转移并非必需,但可诱导其产生化疗耐药性。
Nature. 2015 Nov 26;527(7579):525-530. doi: 10.1038/nature16064. Epub 2015 Nov 11.
5
Epithelial mesenchymal transition (EMT) in prostate growth and tumor progression.上皮-间质转化在前列腺生长和肿瘤进展中的作用
Transl Androl Urol. 2013 Sep 1;2(3):202-211. doi: 10.3978/j.issn.2223-4683.2013.09.04.
6
Tumour-initiating capacity is independent of epithelial-mesenchymal transition status in breast cancer cell lines.肿瘤起始能力与乳腺癌细胞系中上皮-间充质转化状态无关。
Br J Cancer. 2014 May 13;110(10):2514-23. doi: 10.1038/bjc.2014.153. Epub 2014 Apr 22.
7
Epithelial-mesenchymal transition: focus on metastatic cascade, alternative splicing, non-coding RNAs and modulating compounds.上皮-间充质转化:关注转移级联、选择性剪接、非编码 RNA 及调节化合物。
Mol Cancer. 2013 Sep 23;12(1):107. doi: 10.1186/1476-4598-12-107.
8
MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways.miR-200 可通过非 ZEB1 依赖但肌球蛋白依赖的途径抑制乳腺癌转移。
Oncogene. 2014 Jul 31;33(31):4077-88. doi: 10.1038/onc.2013.370. Epub 2013 Sep 16.
9
EVI1 targets ΔNp63 and upregulates the cyclin dependent kinase inhibitor p21 independent of p53 to delay cell cycle progression and cell proliferation in colon cancer cells.EVI1 靶向 ΔNp63 并上调细胞周期蛋白依赖性激酶抑制剂 p21,而不依赖于 p53,以延缓结肠癌细胞的细胞周期进程和增殖。
Int J Biochem Cell Biol. 2013 Aug;45(8):1568-76. doi: 10.1016/j.biocel.2013.04.032. Epub 2013 May 9.
10
EVI1 splice variants modulate functional responses in ovarian cancer cells.EVI1 剪接变异体调节卵巢癌细胞的功能反应。
Mol Oncol. 2013 Jun;7(3):647-68. doi: 10.1016/j.molonc.2013.02.008. Epub 2013 Mar 5.